<DOC>
	<DOCNO>NCT00657943</DOCNO>
	<brief_summary>Type 2 Diabetes Mellitus patient ( T2DM ) increase mortality rate due macrovascular disease . The primary objective study evaluate effect 18-month treatment metformin versus placebo combination one three insulin analogue regimens follow treat-to-target principle . The primary outcome measure change wall thickness carotic artery ( CIMT ) measure ultrasound . A total 900 patient T2DM HbA1c 7.5 % include .</brief_summary>
	<brief_title>The Copenhagen Insulin Metformin Therapy Trial</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Males females 30 year age Type 2 diabetes Body mass index ( BMI ) : 25.039.9 kg/m2 HbA1c 7.5 % Antidiabetic tablettreatment 1 year minimum AND / OR Insulin treatment minimum 3 month Negative pregnancy test Signed , informed consent MI , coronary revascularization , TCI , apoplexy within last 3 month TCI verify stenosis 70 % Heart failure ( NYHA class III IV ) Former cancer patient , unless diseasefree period 5 year estimate creatinine clearance &lt; 60 ml/min Liver disease Alcohol abuse Drug abuse Retinopathy ongoing laser treatment start study Other acute chronic serious disease lead hypoxia Pregnant breastfeed woman Women childbearing potential , use contraceptive Allergy medication use study Incapable understanding nature inform consent</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>carotid</keyword>
	<keyword>intima</keyword>
	<keyword>medium</keyword>
	<keyword>thickness</keyword>
	<keyword>insulin</keyword>
	<keyword>metformin</keyword>
</DOC>